Identification and analysis of mutations in the katG gene in multidrug-resistant mycobacterium tuberculosis clinical isolates;Identyfikacja i analiza mutacji w genie katG w szczepach klinicznych mycobacterium tuberculosis o wielolekooporności typu MDR

Pneumonologia i Alergologia Polska

Volumn 81, Issue 4, 2013, Pages 298-307

  Jagielski, Tomasz ^a   Grzeszczuk, Magdalena ^a   Kamiński, Michał ^a   Roeske, Katarzyna ^a   Napiórkowska, Agnieszka ^b   Stachowiak, Radosław ^a   Augustynowicz Kopeć, Ewa ^b   Zwolska, Zofia ^b   Bielecki, Jacek ^a  

^a UNIVERSITY OF WARSAW   (Poland)

^b NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

KatG; Multidrug resistance; Mutations; Mycobacterium tuberculosis; Sequence analysis; Tuberculosis

Indexed keywords

BACTERIAL PROTEIN; CATALASE; ISONIAZID; KATG PROTEIN, MYCOBACTERIUM TUBERCULOSIS;

CLASSIFICATION; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; MUTATION; MYCOBACTERIUM TUBERCULOSIS; SPECIES DIFFERENCE;

BACTERIAL PROTEINS; CATALASE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; SPECIES SPECIFICITY;

EID: 84878819828     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Jagielski T., Augustynowicz-Kopeć E., Zwolska Z. Epidemiologia gruźlicy w perspektywie świata, Europy i Polski. Wiad. Lek. 2010; 63: 230-246.
2. Jagielski T., Augustynowicz-Kopeć E., Zwolska Z. Epidemiologia gruź-licy lekoopornej: świat-Europa-Polska. Wiad. Lek. 2010; 63: 345-357.
3. Hedgecock L.W., Faucher I.O. Relation of pyrogallol-peroxidative activity to isoniazid resistance in Mycobacterium tuberculosis. Am. Rev. Tuberc. 1957; 75: 670-674.
4. Middlebrook, G. Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report. Am. Rev. Tuberc. 1964; 69: 471-472.
5. Tirunarayanan M.O., Vischer W.A. Relationship of isoniazid to the metabolism of mycobacteria; catalase and peroxidase. Am. Rev. Tuberc. 1957; 75: 62-70.
6. Zhang Y., Garbe T., Young D. Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol. Microbiol. 1993; 8: 521-524.
7. Zhang Y., Heym B., Allen B., Young D., Cole S. The catalase--peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 1992; 358: 591-593.
8. Timmins G.S., Deretic V. Mechanisms of action of isoniazid. Mol. Microbiol. 2006; 62: 1220-1227.
9. Ferrazoli L., Palaci M., Telles M.A., i wsp. Catalase expression, katG, and MIC of isoniazid for Mycobacterium tuberculosis isolates from Sao Paulo, Brazil. J. Infect. Dis. 1995; 171: 237-240.
10. Goto M., Oka S., Tachikawa N., i wsp. KatG sequence deletion is not the major cause of isoniazid resistance in Japanese and Yemeni Mycobacterium tuberculosis isolates. Mol. Cell. Probes 1995; 9: 433-439.
11. Ramaswamy S.V., Reich R., Dou S.J. i wsp. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Myco-bacterium tuberculosis. Antimicrob. Agents Chemother. 2003; 47: 1241-1250.
12. Zhang M., Yue J., Yang Y. P. i wsp. Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J. Clin. Microbiol. 2005; 43: 5477-5482.
13. Zwolska Z., Augustynowicz-Kopeć E., Klatt M. Pierwotna i nabyta lekooporność pra{ogonek}tków gruźlicy w Polsce. Pneumonol. Alergol. Pol. 1999; 67: 536-545.
14. van Embden J.D., Cave M.D., Crawford J.T. i wsp. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 1993; 31: 406-409.
15. Youmans, G.P. The laboratory diagnosis of mycobacterial disease. Philadelphia: W. B. Saunders Co. 1979; 430-431.
16. Cardoso R.F., Cooksey R.C., Morlock G.P. i wsp. Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. Antimicrob. Agents Che-mother. 2004; 48: 3373-3381.
17. Coll P., Aragon L.M., Alcaide F. i wsp. Molecular analysis of isonia-zid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona. Microb. Drug Resist. 2005; 11: 107-114.
18. Guo H., Seet Q., Denkin S., Parsons L., Zhang Y. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA. J. Med. Microbiol. 2006; 55: 1527-1531.
19. Herrera L., Valverde A., Saiz P., Saez-Nieto J.A., Portero J.L., Jimenez M.S. Molecular characterization of isoniazid-resistant Mycobacte-rium tuberculosis clinical strains isolated in the Philippines. Int. J. Antimicrob. Agents 2004; 23: 572-576.
20. Abate G., Hoffner S.E., Thomsen V.O., Miorner H. Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG. Eur. J. Clin. Microbiol. Infect. Dis. 2001; 20: 329-333.
21. Abe C., Kobayashi I., Mitarai S. i wsp. Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan. J. Clin. Microbiol. 2008; 46: 2263-2268.
22. Ahmad S., Mokaddas E. Contribution of AGC to ACC and other mutations at codon 315 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis isolates from the Middle East. Int. J. Antimicrob. Agents 2004; 23: 473-479.
23. Baker L.V., Brown T.J., Maxwell O. i wsp. Molecular analysis of iso-niazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC-46A polymorphism. Antimicrob Agents Chemother. 2005; 49: 1455-1464.
24. Bakonyte D., Baranauskaite A., Cicenaite J., Sosnovskaja A., Stake-nas P. Molecular characterization of isoniazid-resistant Mycobacte-rium tuberculosis clinical isolates in Lithuania. Antimicrob. Agents Chemother. 2003; 47: 2009-2011.
25. Clemente W.T., Soares Lima S.S., Palaci M. i wsp. Phenotypic and genotypic characterization of drug-resistant Mycobacterium tuberculosis strains. Diagn. Microbiol. Infect. Dis. 2008; 62: 199-204.
26. Hazbon, M.H., Brimacombe, M., Bobadilla del Valle, M. i wsp. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. An-timicrob. Agents Chemother. 2006; 50: 2640-2649.
27. Lavender C., Globan M., Sievers A., Billman-Jacobe H., Fyfe J. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia. Antimicrob. Agents Che-mother. 2005; 49: 4068-4074.
28. Musser J.M., Kapur V., Williams D.L., Kreiswirth B.N., van Soolingen D., van Embden J.D. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J. Infect. Dis. 1996; 173: 196-202.
29. Shemyakin I.G., Stepanshina V.N., Ivanov I.Y. i wsp. Characterization of drug-resistant isolates of Mycobacterium tuberculosis derived from Russian inmates. Int. J. Tuberc. Lung Dis. 2004; 8: 1194-1203.
30. Zakerbostanabad S., Titov L.P., Bahrmand A.R. Frequency and molecular characterization of isoniazid resistance in katG region of MDR isolates from tuberculosis patients in southern endemic border of Iran. Infect. Genet. Evol. 2008; 8: 15-19.
31. Zhang S.L., Qi H., Qiu D.L. i wsp. Genotypic analysis of multidrug--resistant Mycobacterium tuberculosis isolates recovered from central China. Biochem. Genet. 2007; 45: 281-290.
32. Kiepiela P., Bishop K.S., Smith A.N., Roux L., York D.F. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tuber. Lung Dis. 2000; 80: 47-56.
33. Mokrousov I., Narvskaya O., Otten T., Limeschenko E., Steklova L., Vyshnevskiy B. High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob. Agents Chemother. 2002; 46: 1417-1424.
34. Tracevska T., Jansone I., Broka L., Marga O., Baumanis V. Mutations in the rpoB and katG genes leading to drug resistance in Mycobacte-rium tuberculosis in Latvia. J. Clin. Microbiol. 2002; 40: 3789-3792.
35. Silva M.S., Senna S.G., Ribeiro M.O. i wsp. Mutations in katG, inhA, and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobac-terium tuberculosis. J. Clin. Microbiol. 2003; 41: 4471-4474.
36. van Soolingen D., de Haas P.E., van Doorn H.R., Kuijper E., Rinder H., Borgdorff M.W. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. J. Infect. Dis. 2000; 182: 1788-1790.
37. Garcia de Viedma D., del Sol Diaz Infantes M., Lasala F., Chaves F., Alcala L., Bouza E. New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis. J. Clin. Microbiol. 2002; 40: 988-995.
38. Rindi L., Bianchi L., Tortoli E., Lari N., Bonanni D., Garzelli C. Mutations responsible for Mycobacterium tuberculosis isoniazid resistance in Italy. Int. J. Tuberc. Lung Dis. 2005; 9: 94-97.
39. Rouse D.A., Li Z., Bai G.H., Morris S.L. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Myco-bacterium tuberculosis. Antimicrob. Agents Chemother. 1995; 39: 2472-2477.
40. Pretorius G.S., van Helden P.D., Sirgel F., Eisenach K.D., Victor T.C. Mutations in katG gene sequences in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis are rare. Antimicrob. Agents Chemother. 1995; 39: 2276-2281.
41. Sajduda A., Brzostek A., Popławska M. i wsp. Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J. Clin. Microbiol. 2004; 42: 2425-2431.
42. Wojtyczka R.D., Dworniczak S., Pacha J. i wsp. PCR-RFLP analysis of a point mutation in codons 315 and 463 of the katG gene of Myco-bacterium tuberculosis isolated from patients in Silesia, Poland. Pol. J. Microbiol. 2004; 53: 89-93.
43. Wengenack N.L., Uhl J.R., St Amand A.L. i wsp. Recombinant Mycobacterium tuberculosis KatG (S315T) is a competent catalase--peroxidase with reduced activity toward isoniazid. J. Infect. Dis. 1997; 176: 722-727.
44. Zhao X., Yu H., Yu S., Wang F., Sacchettini J.C., Magliozzo R.S. Hydrogen peroxide-mediated isoniazid activation catalyzed by My-cobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant. Biochemistry 2006; 45: 4131-4140.
45. Pym A.S., Saint-Joanis B., Cole S.T. Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect. Immun. 2002; 70: 4955-4960.
46. Marttila H.J., Soini H., Eerola E. i wsp. A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug--resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia. Antimicrob. Agents Chemother. 1998; 42: 2443-2445.
47. Marín M., García de Viedma D., Ruíz-Serrano M.J., Bouza E. Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR. Antimicrob. Agents Chemother. 2004; 48: 4293-4300.
48. Piatek A.S., Telenti A., Murray M.R. i wsp. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimi-crob. Agents Chemother. 2000; 44: 103-110.
49. van Doorn H.R., de Haas P.E., Kremer K., Vandenbroucke-Grauls C.M., Borgdorff M.W., van Soolingen D. Public health impact of isonia-zid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands. Clin. Microbiol. Infect. 2006; 12: 769-775.
50. Gagneux S., Burgos M.V., DeRiemer K. i wsp. Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog. 2006; 2: 61.